Phenotyping and follow up of forty-seven Iranian patients with common variable immunodeficiency

Common variable immune deficiency (CVID) is a heterogeneous syndrome with a wide variety of signs and symptoms. This study describes the phenotyping and survival of the CVID patients in the allergy and clinical immunology department of Rasol-E-Akram Hospital of Iran University of Medical Sciences in...

Full description

Saved in:
Bibliographic Details
Published inAllergologia et immunopathologia Vol. 44; no. 3; p. 226
Main Authors Arshi, Saba, Nabavi, Mohammad, Bemanian, Mohammad Hasan, Shakeri, Ramin, Taghvaei, Behrang, Ghalebaghi, Babak, Babaie, Delara, Bahrami, Ahmad, Fallahpour, Morteza, Esmaeilzadeh, Hossein, Rekabi, Mahsa, Amadian, Javad, Eslami, Narjes, Shokri, Sima, Jalali, Farhad, Akbarpour, Nadieh, Molatefi, Rasol, Rezaei, Nima
Format Journal Article
LanguageEnglish
Published Spain 01.05.2016
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Common variable immune deficiency (CVID) is a heterogeneous syndrome with a wide variety of signs and symptoms. This study describes the phenotyping and survival of the CVID patients in the allergy and clinical immunology department of Rasol-E-Akram Hospital of Iran University of Medical Sciences in Tehran. We retrospectively reviewed hospital files of CVID patients in our department until January 2014. All patients were diagnosed with standard diagnostic criteria of CVID, treated and visited monthly, during the follow-up period. We divided the patients into four phenotypes; infection only, cytopenia, polyclonal lymphocytic infiltration and unexplained enteropathy. The immunologic, demographic and clinical findings in different phenotypes were analysed. The study included 47 CVID patients with mean age at onset of symptoms and diagnosis of 11.2 and 20.2 years, respectively. Phenotyping of our patients was: only infection (62%), cytopenia (26%) and PLI (19%) and 94% of cases had only one phenotype. We did not find a significant relation between the clinical phenotypes and immunologic or demographic data. Rate of parental consanguinity in our cases was 47%. Parental consanguinity was related to lower age at onset, lower age at diagnosis and higher baseline IgG levels. Patients with malignancy and autoimmunity had significantly higher age at onset. Our patients were followed-up for 6.9 years and the mortality rate during this time was 6%. Parental consanguinity and age at onset of CVID symptoms may have important roles in CVID manifestations.
ISSN:1578-1267
DOI:10.1016/j.aller.2015.04.005